Incidence of Venous Thromboembolism and Cardiovascular Events in Breast Cancer Patients Undergoing Cyclin-dependent Kinase 4/6 Inhibitors: The Breast Cancer Associated Vascular Events During Cyclin-dependent Kinase 4/6 Inhibitors Therapy (BRAVE-Cyclin) Study

NCT07008508 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Cyclin-dependent Kinase 4/6 Inhibitor

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS